Ativan

Alcohol Withdrawal Delirium, Delirium, Panic Disorder + 12 more

Treatment

20 Active Studies for Ativan

What is Ativan

Lorazepam

The Generic name of this drug

Treatment Summary

Lorazepam is a sedative and anti-anxiety medication that was first developed in 1977 by DJ Richards and was approved by the FDA in 1985. It is a type of benzodiazepine, meaning it acts quickly and is cleared from the body quickly. It is commonly used to help with anxiety and insomnia.

Lorazepam

is the brand name

image of different drug pills on a surface

Ativan Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Lorazepam

Lorazepam

1980

440

Effectiveness

How Ativan Affects Patients

Lorazepam works by increasing the activity of a certain type of brain cell (GABA-A receptors) which helps regulate nerve signals. This helps reduce seizures, as well as cause drowsiness and dizziness. The effects of lorazepam can be felt in different parts of the body, causing different levels of sleepiness and dizziness.

How Ativan works in the body

Lorazepam works by binding to receptors in the brain, specifically those related to GABA. Binding to these receptors increases the flow of chloride ions into the cell, making it more difficult for the cell to fire. Depending on which part of the brain lorazepam binds to, it can help with anxiety or seizure disorders.

When to interrupt dosage

The prescribed dosage of Ativan is based on the diagnosed affliction, including Anxiety Disorders, Generalized Anxiety Disorder and Insomnia. The dosage fluctuates based on the technique of delivery (e.g. Capsule, extended release - Oral or Liquid - Intramuscular; Intravenous) shown in the table beneath.

Condition

Dosage

Administration

Depression

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Preoperative

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Catatonia

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Pharmacotherapy

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Status Epilepticus

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Insomnia

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Generalized Anxiety Disorder

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Anesthetic premedication therapy

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Anxiety Disorders

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Syndrome

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Agitation

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Panic Disorder

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Spasm

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Alcohol Withdrawal Delirium

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Delirium

0.5 mg, , 2.0 mg, 1.0 mg, 2.0 mg/mL, 4.0 mg/mL, 2.5 mg, 3.0 mg, 1.5 mg

, Oral, Tablet, Tablet - Oral, Liquid, Liquid - Oral, Intramuscular; Intravenous, Injection, solution, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Sublingual, Tablet - Sublingual, Solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution, concentrate, Solution, concentrate - Oral, Concentrate, Concentrate - Oral, Intramuscular, Injection - Intramuscular, Capsule, extended release, Capsule, extended release - Oral

Warnings

Ativan has five contraindications, so it should not be taken in cooperation with the ailments listed in the following table.

Ativan Contraindications

Condition

Risk Level

Notes

Obstructive Sleep Apnea (OSA)

Do Not Combine

Respiratory Insufficiency

Do Not Combine

Glaucoma

Do Not Combine

intra-arterial route of administration

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Lorazepam may interact with Pulse Frequency

There are 20 known major drug interactions with Ativan.

Common Ativan Drug Interactions

Drug Name

Risk Level

Description

Azelastine

Major

Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Deutetrabenazine

Major

The risk or severity of sedation and somnolence can be increased when Lorazepam is combined with Deutetrabenazine.

Ethanol

Major

Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Methadone

Major

Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Methadone.

Olanzapine

Major

The risk or severity of adverse effects can be increased when Lorazepam is combined with Olanzapine.

Ativan Toxicity & Overdose Risk

A toxic dose of lorazepam in a mouse is 1850 mg/kg. Signs of a lorazepam overdose include deep sedation, slow breathing, loss of consciousness, and even death. In these cases, emergency medical care should be administered to help eliminate the drug from the body. There is no evidence that lorazepam causes cancer or mutations. Taking doses higher than 40 mg/kg during pregnancy can lead to fetal resorption and higher rates of fetal loss.

image of a doctor in a lab doing drug, clinical research

Ativan Novel Uses: Which Conditions Have a Clinical Trial Featuring Ativan?

1152 active clinical trials are being conducted to assess the potential of Ativan in providing relief from Anxiety Disorders, Generalized Anxiety Disorder and Insomnia.

Condition

Clinical Trials

Trial Phases

Generalized Anxiety Disorder

181 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 4, Phase 1, Phase 3

Anxiety Disorders

55 Actively Recruiting

Phase 2, Not Applicable, Phase 4, Phase 3, Early Phase 1

Preoperative

0 Actively Recruiting

Syndrome

4 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Anesthetic premedication therapy

0 Actively Recruiting

Insomnia

0 Actively Recruiting

Panic Disorder

13 Actively Recruiting

Not Applicable

Alcohol Withdrawal Delirium

0 Actively Recruiting

Agitation

3 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Delirium

26 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Early Phase 1

Catatonia

0 Actively Recruiting

Status Epilepticus

0 Actively Recruiting

Depression

305 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Pharmacotherapy

1 Actively Recruiting

Not Applicable

Spasm

0 Actively Recruiting

Ativan Reviews: What are patients saying about Ativan?

5

Patient Review

6/3/2018

Ativan for Anxious

Ativan has been a game-changer for me. I was an absolute wreck after my husband was placed in a nursing home, but this medication has helped me to cope and get through each day.

5

Patient Review

8/27/2019

Ativan for Anxious

This pill is great. It has helped me calm down and sleep for many years. I only use it occasionally because it's hard to get from my doctor, but if it were up to me I would take one pill every day.

5

Patient Review

7/10/2020

Ativan for Chronic Trouble Sleeping

I take one tablet of Ativan about an hour or two before bedtime. It usually helps me sleep through the night, and I wake up feeling rested after 7-8 hours. I'm not too worried about addiction at my age (84 years old).

5

Patient Review

8/30/2020

Ativan for Anxious

This treatment has been really effective for my anxiety. Within an hour of taking it, I feel completely normal again. The only side effect I've experienced is feeling really tired once it wears off.

5

Patient Review

4/6/2021

Ativan for Anxious

On the days that I take this medication, I feel much more level-headed and calm. It's been a lifesaver for managing my anxiety. The only downside is that it can make me quite tired in the afternoon, but that just means I sleep better at night.

5

Patient Review

2/25/2022

Ativan for Chronic Trouble Sleeping

I tried this treatment on myself with CBD to see if it would help me fall asleep. I didn't experience any effects other than feeling very sleepy when I woke up. It was difficult to get out of bed in the morning.

5

Patient Review

9/23/2022

Ativan for A Feeling of Restlessness with Inability to Sit Still

Dr. Lynn, I'm proud to say that I'm no longer an alcoholic or drug addict. I only have a drink when I go out to dinner now. I do take prescribed drugs to help me sleep, though, because the pain from my cancer is excruciating. But I only take medication when I absolutely need it.

5

Patient Review

10/21/2021

Ativan for Muscle Spasm

This medication saved my life and I would recommend it to anyone.

5

Patient Review

10/27/2021

Ativan for Muscle Spasm

I liked this medication and would recommend it to others.

5

Patient Review

5/10/2019

Ativan for Anxious

This medication helped me a lot with stress, anxiety, and insomnia. I was also really pleased to find that it masked the ringing in my ears (tinnitus) which had been causing me a lot of anxiety.

5

Patient Review

10/27/2021

Ativan for Muscle Spasm

This was a great experience.

4.3

Patient Review

2/5/2018

Ativan for Anxious

I've used this medication for two decades now, and it's been a big help. I had (and sometimes still have) issues with my inner ear which caused vertigo spells. This was the only drug that helped me get any relief. And as an added bonus, it also calms my anxiety related to the vertigo.

4.3

Patient Review

11/6/2018

Ativan for Anxious

I had a really tough time withdrawing from this medication. It was honestly terrible and took me an entire year to get off of it.

4

Patient Review

6/6/2020

Ativan for Mania associated with Bipolar Disorder, Adjunct Treatment

I take one milligram of this medication whenever I start feeling anxious or before bed if insomnia is plaguing me. It's really effective and doesn't come with any nasty side effects like drowsiness the next day.

1

Patient Review

7/31/2022

Ativan for Anxious

Ineffective for panic attacks and generally made me feel pretty terrible. I'll never touch it again.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ativan

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Xanax the same as Ativan?

"Ativan and Xanax are both effective benzodiazepines for treating anxiety. However, Xanax takes effect more quickly but doesn't last as long as Ativan (4 to 6 hours vs. 8 hours)."

Answered by AI

What exactly does Ativan do?

"This drug is used to treat anxiety by enhancing the effects of a natural chemical in the body called GABA."

Answered by AI

Is Ativan a sleeping pill?

"Ativan is approved by the FDA to be used in the short term to treat insomnia that is caused by anxiety or stress. However, it is not the preferred medication to use for this purpose according to the American Academy of Sleep Medicine."

Answered by AI

Is Ativan a good drug for anxiety?

"Xanax and Ativan are effective for both emotional and physical symptoms of anxiety, as well as panic disorder. However, the risks associated with these medications mean that they are not always the first choice of treatment for either condition. Xanax and Ativan cause anti-anxiety effects quickly, usually within an hour or two of taking the medication."

Answered by AI

Clinical Trials for Ativan

Image of Northwestern University in Evanston, United States.

Sleep and Dreaming Practices for Anxiety

18+
All Sexes
Evanston, IL

People spend approximately one-third of their lives asleep, yet sleep is often underused as an opportunity to support psychological well-being. Contemplative traditions, including Tibetan Dream Yoga, have developed practices that use waking imagination and lucid dreaming to explore perception, awareness, and habitual patterns of thinking. Recent advances in sleep monitoring, dream communication, and lucid dream induction now make it possible to study these practices using scientific methods. This study is a randomized controlled trial designed to examine the feasibility and effects of a Dream-Yoga-inspired intervention compared with an active control condition. The intervention combines waking and dreaming practices that are adapted for individuals without prior experience and delivered using virtual reality-based training and home sleep technology. The program is designed to be scalable and culturally neutral, without requiring prior knowledge of contemplative or religious traditions. The primary goals of the study are to characterize sleep and waking neurophysiology associated with Dream-Yoga-inspired practices and to evaluate whether participation is associated with changes in sleep-related brain activity and cognitive processes. Outcomes include measures of lucid dreaming, sleep physiology, and waking cognitive and perceptual processes. Anxiety will be assessed as an exploratory outcome to examine whether participation may be associated with changes in emotional experience. This study is not designed to provide treatment for anxiety or other clinical conditions. Results from this study will help inform the development of scalable sleep-based mental training approaches and guide future research on the use of dreaming and sleep practices to support psychological health and well-being

Phase < 1
Waitlist Available

Northwestern University (+1 Sites)

Image of Michael E. DeBakey VA Medical Center, Houston, TX in Houston, United States.

Acceptance and Commitment Therapy for Inflammatory Bowel Disease

18+
All Sexes
Houston, TX

Many Veterans with gastrointestinal disorders, such as inflammatory bowel disease (IBD), also have mental health conditions. IBD and mental health conditions can worsen one another through the brain-gut axis, leading to dramatic deficits in psychosocial functioning and quality of life (QOL). Yet, few Veterans with comorbid IBD and mental health conditions receive psychotherapy and no evidence-based psychotherapies have been tested in Veterans with these comorbidities. Adapting brief acceptance and commitment therapy (ACT) to the specific to the needs of these patients and embedding treatment into routine gastroenterology care may increase Veterans' access to efficient and effective rehabilitative care. This study aims to adapt and test an integrated, 1-Day ACT intervention tailored to the specific needs of Veterans with IBD and mental health conditions to improve psychosocial functioning and QOL.

Waitlist Available
Has No Placebo

Michael E. DeBakey VA Medical Center, Houston, TX

Mackenzie Lynmarie Shanahan, PhD

Image of University of Michigan in Ann Arbor, United States.

Virtual Reality for Depression in Multiple Sclerosis

18+
All Sexes
Ann Arbor, MI

This trial explores the use of immersive virtual reality (VR) nature-based experiences as a supplementary treatment for depression in individuals with progressive multiple sclerosis (MS). This study will evaluate the feasibility and efficacy of at-home VR deployment using the Apple Vision Pro, an advanced device that offers enhanced resolution, immersion, and usability compared to earlier VR systems. The study hypotheses include: * The integration of VR nature-based experiences with standard care will be feasible, acceptable, and will result in greater reductions in depressive symptoms compared to standard care or VR-only interventions. * The integration of VR nature-based experiences with standard care will result in greater reductions in stress and anxiety, better sleep, less insomnia, and improved fatigue compared to standard care alone or VR-only interventions.

Recruiting
Has No Placebo

University of Michigan

Hala Darwish, PhD

Apple Inc.

Have you considered Ativan clinical trials?

We made a collection of clinical trials featuring Ativan, we think they might fit your search criteria.
Go to Trials
Image of Liao Lab at UCSF in San Francisco, United States.

Audio-Based Therapy for Anxiety in Psoriasis

18+
All Sexes
San Francisco, CA

Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.

Waitlist Available
Behavior

Liao Lab at UCSF

Wilson Liao, MD

Image of University of Rochester Medical Center in Rochester, United States.

Medical Cannabis for Nausea and Vomiting

18+
All Sexes
Rochester, NY

Many people receiving chemotherapy experience nausea despite standard anti-nausea medications. Medical cannabis is commonly used to help manage nausea, but there is limited scientific evidence about its effectiveness when used alongside modern chemotherapy treatments. This study will evaluate whether medical cannabis can reduce nausea in adults receiving moderately or highly nausea-causing chemotherapy. Participants will be randomly assigned to start medical cannabis either immediately or after one chemotherapy cycle, allowing comparison of symptoms with and without cannabis use. All participants will continue their usual anti-nausea medications. The study will also examine effects on vomiting, appetite, pain, fatigue, sleep, mood, quality of life, and inflammation. Results from this pilot study will help determine the safety, feasibility, and potential benefits of medical cannabis for chemotherapy-related nausea and guide future larger clinical trials.

Phase 2
Waitlist Available

University of Rochester Medical Center

Have you considered Ativan clinical trials?

We made a collection of clinical trials featuring Ativan, we think they might fit your search criteria.
Go to Trials
Image of San Luis Obispo County Juvenile Hall in San Luis Obispo, United States.

Multi-Sensory Therapy for Emotional Dysregulation

12 - 18
All Sexes
San Luis Obispo, CA

Emotional dysregulation in justice-involved youth (JIY) is a condition that significantly impacts young people, their families, and juvenile justice and public health systems. Affecting an estimated 60-70% of detained Attention deficit hyperactivity disorderadolescents, it is a major driver of aggression, substance use, school failure, and later recidivism. Despite available treatments, managing emotional dysregulation in custody remains challenging, with youth often enduring high arousal, anger, and anxiety that persist into adulthood. Current popular therapies, including Cognitive Behavioral Therapy (CBT) and Dialectic Behavioral Therapy (DBT), often fall short in detention because they rely on verbal processing, require multiple scheduled sessions, and/or need highly trained staff. Other technologies, like biofeedback and neurostimulation techniques, are still under scrutiny for adolescents, given their higher-than-usual Adverse Events (AEs). This SoundHeal study aims to evaluate a sensory intervention using the Healpod, a distraction-free physical space where a participant sits, delivering sound, music, gentle vibrations, and ambient light. Following this is a brief expressive journaling exercise to compare any before, during and after experience changes from the sensory immersion. This prospective, single-center cohort study hypothesizes that these sessions will improve juveniles' ability to emotionally regulate, improve therapeutic alliance, mental health outcomes and build coping skills that can potentially help in long-term mental health and substance abuse treatment in JIY and beyond.

Recruiting
Has No Placebo

San Luis Obispo County Juvenile Hall

Nishat Bhuiyan, PhD

SoundHeal

Image of University of South Florida in Tampa, United States.

Web-Based Program for Parenting Stress

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to evaluate the feasibility, usability, and preliminary benefits of implementing ACT Together for parents of children with disabilities in pediatric outpatient clinics. ACT Together includes six self-paced, web-based modules and brief weekly one-on-one coaching sessions led by a trained occupational therapist. The program is based on acceptance and commitment therapy (ACT), which teaches practical skills to help people handle stress and difficult thoughts or feelings while taking steps toward what matters to them. The main questions this study aims to answer are: * Can parents and occupational therapists complete the study activities as planned (e.g., module completion, coaching sessions, and surveys)? * Is the program usable and acceptable/appropriate/feasible to implement in this setting? * Do parents show improvements in mental health and coping-related outcomes after participating in the program? * What are the experiences and perspectives of parents and therapists regarding the program? Parents as participants will: * Complete six self-paced web-based modules and brief weekly individual coaching sessions with a trained occupational therapist. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experiences and perspectives on the program. Occupational therapists as participants will: * Complete therapist training materials and deliver brief individual coaching sessions to parent participants, including completing a post-session checklist. * Complete brief online questionnaires before starting and after delivering the program. * Take part in one online interview about their experiences and perspectives on the program.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han, PhD

Image of Worcester Recovery Center and Hospital in Worcester, United States.

Changing Lives and Changing Outcomes-9 for Serious Mental Illness

18+
All Sexes
Worcester, MA

People with serious mental illness (depression, bipolar, and schizophrenia spectrum disorders) have high rates of repeated criminal legal involvement and psychiatric hospitalizations. Longstanding research shows that in addition to treating clients' symptoms of mental illness, targeting risk factors for legal involvement can help reduce their chances of future incarcerations. Because hospitals are becoming increasingly forensic, treatment programs that address both mental illness and risk factors for legal involvement may be especially helpful in a state hospital setting, like Worcester Recovery Center and Hospital (WRCH). This treatment study offers an adjunctive 9-session intervention, Changing Lives and Changing Outcomes-9 (CLCO-9), for patients at WRCH; this program is designed to help people with serious mental illness who are involved in the legal system increase their awareness of their mental health and reduce their chances of future legal involvement. The investigators are proposing a treatment study testing the use of the CLCO-9 group intervention with patients with serious mental illness with current or previous criminal legal involvement at Worcester Recovery Center and Hospital (WRCH). The study has three aims: 1. Evaluate feasibility, fidelity, and patient satisfaction during the implementation of the CLCO-9 group treatment at WRCH 2. Evaluate CLCO-9's effectiveness on improving patient's self-reported mental health, and behavioral indicators of mental health and risk factors for legal involvement 3. Explore changes in WRCH clinicians' knowledge and attitudes about treating risk factors for criminal legal involvement. To test these aims, the research team will employ a two-phase study. In the first phase, the researchers will implement the intervention and make necessary adjustments to maximize the success of the implementation. In the second phase, the researchers will evaluate the treatment program's effectiveness in producing change from pre- to post-treatment. All patient participants in this study will receive the intervention. The projected sample size is about 20 treatment completers and 4 to 8 group leaders.

Waitlist Available
Has No Placebo

Worcester Recovery Center and Hospital

Faith Scanlon, PhD

Have you considered Ativan clinical trials?

We made a collection of clinical trials featuring Ativan, we think they might fit your search criteria.
Go to Trials